Seaport loads up $225M series B to continue Karuna veterans' …

Oct 21, 2024 · After launching on its maiden voyage in April, Seaport Therapeutics and its crew of Karuna veterans have loaded up with $225 million in series B funds to support the journey to …

CouponFollow Extension

$225
OFF

Seaport Loads Up $225M Series B To Continue Karuna Veterans' …

1 week from now

Oct 21, 2024 · After launching on its maiden voyage in April, Seaport Therapeutics and its crew of Karuna veterans have loaded up with $225 million in series B funds to support the journey to …

fiercebiotech.com

$225
OFF

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a …

seaporttx.com

$225
OFF

Seaport, Six Months Out Of Stealth, Comes Back For $225M Raise

1 week from now

Oct 21, 2024 · Seaport Therapeutics, just six months after emerging from stealth with $100 million, is back with twice that value in additional funding to support its neuropsychiatric …

biospace.com

$225
OFF

Seaport Docks $225m For Its Improved Neuropsychiatry Drugs

1 week from now

Nov 12, 2024 · Seaport Therapeutics completes a $225m Series B to ... After emerging from the shadows with a $100 million Series A in April, Seaport Therapeutics has moved swiftly to …

pharmaphorum.com

$225
OFF

PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...

1 week from now

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …

businesswire.com

$225
OFF

Seaport Eyes Platform, Pipeline Growth With $225M Series B

1 week from now

Oct 21, 2024 · Seaport has closed on an oversubscribed $225 million Series B financing, with the proceeds set to be used toward enhancing the platform, and advancing through clinical …

genengnews.com

$225
OFF

Seaport Raises $225m To Advance Portfolio Of Neuropsychiatric …

1 week from now

Oct 21, 2024 · GLDAF. PureTech-founded Seaport Therapeutics has raised $225m in a Series B financing round to support the development of new prodrug treatments for psychiatric …

yahoo.com

$225
OFF

PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...

1 week from now

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …

ft.com

$225
OFF

Seaport, Six Months Out Of Stealth, Comes Back For $225M Raise

1 week from now

Oct 21, 2024 · Seaport, Six Months Out of Stealth, Comes Back for $225M Raise. By / 21/10/2024 21/10/2024. Seaport Therapeutics, kick started by the former leaders of Karuna …

convitgroup.com

$225
OFF

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

Oct 21, 2024 · Seaport is led by an experienced team that invented and advanced important neuropsychiatric medicines and are guided by an extensive network of renowned scientists, …

businesswire.com

$225
OFF

Seaport Loads Up $225M Series B To Continue Karuna Veterans' …

1 week from now

Oct 21, 2024 · Seaport loads up $225M series B to continue Karuna veterans' voyage to clinical milestones jwaldron Mon, 10/21/2024 - 04:43 ... Biotech News; Post a Biotech Job; Close …

biotechjobs.io

$225
OFF

Seaport Loads Up $225M Series B To Continue Karuna Veterans' …

1 week from now

After launching on its maiden voyage in April, Seaport Therapeutics and its crew of Karuna veterans have loaded up with $225 million in series B fu...

biotech-now.co.uk

$225
OFF

Seaport Therapeutics Closes $225M Series B Financing Round

1 week from now

Oct 21, 2024 · Seaport Therapeutics, a Boston, MA-based biopharmaceutical company that is developing novel neuropsychiatric medicines, raised $225M in Series B funding.. The round, …

finsmes.com

99%
OFF

PureTech's Seaport Closes $225m Series B Round

1 week from now

Oct 21, 2024 · At 1106 BST, shares in PureTech Health were up 1.99% at 153.6p. Reporting by Josh White for Sharecast.com. PureTech Health announced on Monday that Seaport …

sharecast.com

$225
OFF

PRTC's Seaport Closes $225M Series B Financing

1 week from now

21 October 2024. 21 October 2024. PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. Financing led by General Atlantic with …

sharesmagazine.co.uk

$225
OFF

Seaport Therapeutics Raises $225M Series B - Chemical

1 week from now

Oct 27, 2024 · Seaport Therapeutics, a start-up developing psychiatric treatments, has raised $225 million in a series B funding round—for a total of $325 million since its launch in April.The …

acs.org

$225
OFF

Intelisci On LinkedIn: Seaport Loads Up $225M Series B To Continue ...

1 week from now

Seaport Therapeutics, led by the same pioneers who built Karuna Therapeutics, has just secured $225M in #SeriesB funding to advance its pipeline of neuropsychiatric treatments. This …

linkedin.com

$225
OFF

Former Karuna Crew Quickly Assembles $225M For Next Neuro Bet …

1 week from now

Oct 21, 2024 · Former Karuna crew quickly assembles $225M for next neuro bet at Seaport. Seaport Therapeutics CEO Daphne Zohar at the Endpoints 11 gala (Michael Last …

endpts.com

$225
OFF

David Claveau On LinkedIn: Seaport Loads Up $225M Series B To …

1 week from now

Karuna's veterans, now with Seaport Therapeutics, ... Seaport loads up $225M series B to continue Karuna veterans' voyage to clinical milestones fiercebiotech.com 18 ...

linkedin.com

$14
OFF

Karuna's Captains Set Sail In New Neuropsychiatric Biotech

1 week from now

Apr 9, 2024 · Seaport’s leadership has been buoyed by the fate of Karuna, which was acquired by BMS for $14 billion in December so the Big Pharma could get its hands on what looks set to …

fiercebiotech.com

FAQs about Seaport loads up $225M series B to continue Karuna veterans' … Coupon?

What is seaport doing with $225m funding?

Seaport will use the $225m funding to advance its pipeline of experimental drugs for neuropsychiatric disorders. Credit: eamesBot via Shutterstock. ·Pharmaceutical Technology·eamesBot via Shutterstock. ...

What will seaport's spt-300 funding mean for glyph?

The financing will accelerate the development of Seaport's clinical-stage pipeline and Glyph platform, the company said. Leading Seaport’s armada of candidates is SPT-300, a prodrug of allopregnanolone—a naturally occurring neurosteroid that is marketed as Zulresso as an injection to treat postpartum depression. ...

Does Seaport have a glyph platform?

Seaport is also working on SPT-320, a prodrug of agomelatine—an antidepressant available in Europe as Valdoxan but not approved by the FDA. The company hopes its Glyph platform can lower the dose needed for the drug’s effectiveness by reducing its metabolism in the liver and therefore removing the need for liver function monitoring. ...

Who financed seaport's spt-300 Phase IIa trial?

Topline results from Seaport’s SPT-300 Phase IIa proof-of-concept trial were reported in November 2023, where the study met its primary endpoint of salivary cortisol response. The financing was led by General Atlantic, with backing from several other major investors such as T Rowe Price, Foresite Capital, and Goldman Sachs. ...

What is seaport spt-348?

Seaport is also developing SPT-348 for mood and neuropsychiatric disorders and has several preclinical programmes under its belt. Prodrugs are medications that start as inactive or less active, and once inside the body, are converted into the active form, usually through natural processes involving enzymes. ...

Does Seaport have a drug pipeline?

Seaport plans to use the new funds to push forward its pipeline of experimental drugs, including its most advanced candidate, SPT-300, which is being advanced into a Phase IIb trial for major depressive disorder. SPT-300 is an oral prodrug of brexanolone, a neurosteroid compound with known anti-depressant effects. ...